Year: 2026
Type: preprint
Abstract: Proton pump inhibitors (PPIs) consistently alter the gut microbiome, but the contribution of these changes to systemic effects associated with PPI use remains unclear. Here, we show that PPI-associated microbiome remodelling induces systemic metabolic and transcriptional responses independently of direct drug exposure. Integrating human microbiome and metabolomics data with metabolic modelling, we identified consistent alterations in microbial metabolic functions and host-microbiome co-metabolism. Transfer of PPI-associated microbiota into germ-free mice reproduced key metabolic changes observed in humans, particularly in aromatic amino acid metabolism, and induced additional alterations in systemic lipid metabolism. These changes were accompanied by tissue-specific transcriptional responses in the colon, liver and brain, affecting metabolic and inflammatory pathways. Together, our findings identify transferable metabolic and transcriptional microbiome-mediated signatures that may contribute to the adverse systemic effects associated with PPI use.
Authors: Karlis Arturs Moors, Saskia Weber-Stiehl, Hannah Jebens, Bram Nap, Daniel Faessler, Ameneh Mehrjerd, Martina A Guggeis, Silke S Heinzmann, Alesia Walker, Corinna Bang, Fenja Amrei Schuran, Georgios Marinos, Kristina Schlicht, Jennifer Hoerloeck, Jan Taubenheim, Andre Franke, Wolfgang Lieb, Matthias Laudes, Almut Heinken, Philippe Schmitt-Kopplin, Philip Rosenstiel, Johannes Hertel, Ines Thiele, Mathieu Groussin, Mathilde Poyet, Felix Sommer, Christoph Kaleta
Institutions: Institute of Experimental Medicine, Christian-Albrechts-Universität zu Kiel, University Hospital Schleswig-Holstein, Ollscoil na Gaillimhe – University of Galway, Universitätsmedizin Greifswald, Helmholtz Munich, Inserm, Nutrition-Génétique et Exposition aux Risques Environnementaux, Université de Lorraine
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7225908448
